Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)
China
· Delayed Price · Currency is CNY 3.640
+0.010 (0.28%)
Jun 11, 2025, 1:45 PM CST
SHE:002390 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 5,859 | 6,000 | 6,436 | 6,331 | 6,441 | 5,819 | Upgrade
|
Other Revenue | 32.17 | 32.17 | 24.98 | 19.36 | 30.76 | 26.18 | Upgrade
|
| Revenue | 5,891 | 6,032 | 6,461 | 6,350 | 6,472 | 5,846 | Upgrade
|
Revenue Growth (YoY) | -8.50% | -6.63% | 1.75% | -1.88% | 10.71% | -12.16% | Upgrade
|
Cost of Revenue | 4,903 | 5,000 | 5,240 | 5,133 | 5,119 | 4,594 | Upgrade
|
Gross Profit | 988.45 | 1,032 | 1,221 | 1,217 | 1,352 | 1,252 | Upgrade
|
Selling, General & Admin | 648.06 | 669.9 | 737.84 | 814.14 | 766.62 | 775.52 | Upgrade
|
Research & Development | 4.43 | 4.59 | 4.67 | 1.21 | 1.94 | 10.56 | Upgrade
|
Other Operating Expenses | 25.92 | 25.01 | 22.57 | 28.19 | 28.7 | 23.91 | Upgrade
|
Operating Expenses | 726.21 | 749.07 | 830.01 | 884.14 | 823.94 | 847.94 | Upgrade
|
Operating Income | 262.24 | 282.84 | 391.05 | 332.82 | 528.56 | 403.64 | Upgrade
|
Interest Expense | -22.67 | -23.54 | -39.7 | -51.79 | -100.19 | -99.61 | Upgrade
|
Interest & Investment Income | 10.85 | 10.76 | 22.13 | 50.97 | 17.92 | 15.37 | Upgrade
|
Currency Exchange Gain (Loss) | -0 | -0 | 0 | 0 | -0 | 2.3 | Upgrade
|
Other Non Operating Income (Expenses) | -17.93 | -18.96 | 11.01 | -22.76 | -4.47 | -23.5 | Upgrade
|
EBT Excluding Unusual Items | 232.49 | 251.1 | 384.49 | 309.25 | 441.82 | 298.19 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | - | - | - | -16.97 | Upgrade
|
Gain (Loss) on Sale of Assets | -2.24 | -2.29 | 0.02 | -0 | -0.42 | -1.7 | Upgrade
|
Asset Writedown | -1.11 | -1.11 | -0.56 | -2.13 | -4.04 | -2.65 | Upgrade
|
Other Unusual Items | -62.13 | -62.2 | 12.08 | 6.28 | -16.23 | -9.42 | Upgrade
|
Pretax Income | 167.01 | 185.5 | 396.02 | 313.39 | 421.12 | 267.46 | Upgrade
|
Income Tax Expense | 29.15 | 29.81 | 42.25 | 45.14 | 47.17 | 46.88 | Upgrade
|
Earnings From Continuing Operations | 137.86 | 155.69 | 353.77 | 268.26 | 373.96 | 220.58 | Upgrade
|
Minority Interest in Earnings | -54.06 | -54.31 | -66.54 | -43.88 | -101.09 | -47.05 | Upgrade
|
Net Income | 83.8 | 101.38 | 287.23 | 224.37 | 272.87 | 173.52 | Upgrade
|
Net Income to Common | 83.8 | 101.38 | 287.23 | 224.37 | 272.87 | 173.52 | Upgrade
|
Net Income Growth | -71.41% | -64.70% | 28.02% | -17.77% | 57.25% | -26.57% | Upgrade
|
Shares Outstanding (Basic) | 2,053 | 2,028 | 1,915 | 1,870 | 1,819 | 1,577 | Upgrade
|
Shares Outstanding (Diluted) | 2,053 | 2,028 | 1,915 | 1,870 | 1,819 | 1,577 | Upgrade
|
Shares Change (YoY) | 4.54% | 5.89% | 2.41% | 2.79% | 15.32% | 0.14% | Upgrade
|
EPS (Basic) | 0.04 | 0.05 | 0.15 | 0.12 | 0.15 | 0.11 | Upgrade
|
EPS (Diluted) | 0.04 | 0.05 | 0.15 | 0.12 | 0.15 | 0.11 | Upgrade
|
EPS Growth | -72.65% | -66.67% | 25.00% | -20.00% | 36.36% | -26.67% | Upgrade
|
Free Cash Flow | 588.59 | 510.1 | 654.84 | 432.02 | 204.21 | 604.02 | Upgrade
|
Free Cash Flow Per Share | 0.29 | 0.25 | 0.34 | 0.23 | 0.11 | 0.38 | Upgrade
|
Dividend Per Share | 0.060 | 0.060 | 0.060 | 0.060 | 0.060 | - | Upgrade
|
Gross Margin | 16.78% | 17.11% | 18.90% | 19.16% | 20.90% | 21.41% | Upgrade
|
Operating Margin | 4.45% | 4.69% | 6.05% | 5.24% | 8.17% | 6.91% | Upgrade
|
Profit Margin | 1.42% | 1.68% | 4.45% | 3.53% | 4.22% | 2.97% | Upgrade
|
Free Cash Flow Margin | 9.99% | 8.46% | 10.13% | 6.80% | 3.16% | 10.33% | Upgrade
|
EBITDA | 465.35 | 491.06 | 619.72 | 567.89 | 767.42 | 635.29 | Upgrade
|
EBITDA Margin | 7.90% | 8.14% | 9.59% | 8.94% | 11.86% | 10.87% | Upgrade
|
D&A For EBITDA | 203.11 | 208.22 | 228.67 | 235.06 | 238.86 | 231.65 | Upgrade
|
EBIT | 262.24 | 282.84 | 391.05 | 332.82 | 528.56 | 403.64 | Upgrade
|
EBIT Margin | 4.45% | 4.69% | 6.05% | 5.24% | 8.17% | 6.91% | Upgrade
|
Effective Tax Rate | 17.45% | 16.07% | 10.67% | 14.40% | 11.20% | 17.53% | Upgrade
|
Revenue as Reported | 5,891 | 6,032 | 6,461 | 6,350 | 6,472 | 5,846 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.